NICE guidance on olaparib for maintenance treatment of patients with relapsed, platinum-sensitive, BRCA mutation-positive ovarian cancer. Issue 3 (March 2016) - Tucker, Helen; Charles, Zoe; Robertson, Janet; Adam, Jane